Internal Medicine, Infectious Disease · Little Rock, AR
NPI
1730279217
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4301 W Markham St # 783
Little Rock, AR, 72205
Phone (501) 686-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
263 services
Medicare patients, 2024
96
Average age 63
Drug cost, 2024
$1.7M
936 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Saccente was code 99233 (hospital e&m - subsequent), 71 times for 28 patients. In total Michael Saccente billed 263 services in 13 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 71 | 28 | $84.84 | $6,024 |
| 99223 Hospital E&M - Initial | Facility | 44 | 43 | $124.16 | $5,463 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 44 | 27 | $11.47 | $504 |
| 99214 Office E&M - Established | Facility | 36 | 26 | $62.29 | $2,243 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 19 | $55.83 | $1,507 |
| 99213 Office E&M - Established | Facility | 17 | 11 | $42.17 | $717 |
By year: 2022 $15K for 209 services; 2023 $12K for 161 services; 2024 $18K for 263 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Saccente prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 145 prescriptions and refills. In total Michael Saccente wrote 936 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 145 | 145 | 14 | $556K |
| Tivicay Dolutegravir Sodium | 62 | 62 | Under 11 | $135K |
| Prezcobix Darunavir/Cobicistat | 61 | 61 | Under 11 | $144K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 53 | 53 | Under 11 | $190K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 40 | 40 | Under 11 | $145K |
| Sodium Chloride 0.9 % Sodium Chloride | 38 | 38 | Under 11 | $268 |
| Descovy Emtricitabine/Tenofov Alafenam | 36 | 36 | Under 11 | $76K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 35 | 35 | Under 11 | $144K |
| Vancomycin Hcl Generic | 34 | 34 | Under 11 | $4,460 |
| Daptomycin Generic | 28 | 28 | Under 11 | $32K |
| Doxycycline Hyclate Generic | 27 | 29 | Under 11 | $827 |
| Abacavir Abacavir Sulfate | 23 | 23 | Under 11 | $2,103 |
| Emtricitabine Generic | 20 | 20 | Under 11 | $7,204 |
| Edurant Rilpivirine Hcl | 19 | 19 | Under 11 | $27K |
| Ceftriaxone Ceftriaxone Sodium | 17 | 17 | Under 11 | $629 |
Brand drugs: 558 claims; generic drugs: 378 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Michael Saccente were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.